{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:45Z","timestamp":1791849525053,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11046-016-0061-0","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T12:35:19Z","timestamp":1473683719000},"page":"815-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Usage of 1,3-\u03b2-d-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients"],"prefix":"10.1007","volume":"181","author":[{"given":"Tobias","family":"Lahmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schnappauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analena","family":"Beitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"issue":"2","key":"61_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Intensive Care Med. 2013;39(2):165\u2013228.","journal-title":"Intensive Care Med"},{"key":"61_CR2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc2917","volume":"8","author":"WT Linde-Zwirble","year":"2004","unstructured":"Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8:222\u20136.","journal-title":"Crit Care"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/01.CCM.0000262946.68003.21","volume":"35","author":"VY Dombrovskiy","year":"2007","unstructured":"Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1414\u20135.","journal-title":"Crit Care Med"},{"issue":"21","key":"61_CR4","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, et al. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323\u20139.","journal-title":"JAMA"},{"issue":"5","key":"61_CR5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","volume":"65","author":"WJ Steinbach","year":"2012","unstructured":"Steinbach WJ, Marr KA, Anaissie EJ, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. 2012;65(5):453\u201364.","journal-title":"J Infect"},{"issue":"3","key":"61_CR6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/civ293","volume":"61","author":"OA Cornely","year":"2015","unstructured":"Cornely OA, Gachot B, Akan H, et al. EORTC Infectious Diseases Group. Epidemiology and outcome of fungemia in a cancer cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis. 2015;61(3):324\u201331.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"61_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diagmicrobio.2012.02.020","volume":"73","author":"EL Ericson","year":"2012","unstructured":"Ericson EL, Klingspor L, Ullberg M, Ozenci V. Clinical comparison of the Bactec Mycosis IC\/F, BacT\/Alert FA, and BacT\/Alert FN blood culture vials for the detection of candidemia. Diagn Microbiol Infect Dis. 2012;73(2):153\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"61_CR8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al. European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"61_CR9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3324\/haematol.2013.094359","volume":"98","author":"M Nucci","year":"2013","unstructured":"Nucci M, Nou\u00e9r SA, Cappone D, Anaissie E. Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome. Haematologica. 2013;98(11):1657\u201360.","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"61_CR10","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","volume":"47","author":"FM Marty","year":"2009","unstructured":"Marty FM, Koo S. Role of (1\u21923)-\u03b2-d-glucan in the diagnosis of invasive aspergillosis. Med Mycol. 2009;47(Suppl 1):S233\u201340.","journal-title":"Med Mycol"},{"issue":"10","key":"61_CR11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","volume":"5","author":"WW Hope","year":"2005","unstructured":"Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis. 2005;5(10):609\u201322 (Review).","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"61_CR12","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1128\/JCM.43.12.5957-5962.2005","volume":"43","author":"JW Pickering","year":"2005","unstructured":"Pickering JW, Sant HW, Bowles CA, et al. Evaluation of a (1\u21923)-\u03b2-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2005;43(12):5957\u201362.","journal-title":"J Clin Microbiol"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/JCM.01737-13","volume":"51","author":"ES Theel","year":"2013","unstructured":"Theel ES, Doern CD. \u03b2-d-Glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol. 2013;51:3478\u201383.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"61_CR14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","volume":"52","author":"DE Karageorgopoulos","year":"2011","unstructured":"Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. \u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis. 2011;52(6):750\u201370.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"61_CR15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","volume":"54","author":"F Lamoth","year":"2012","unstructured":"Lamoth F, Cruciani M, Mengoli C, et al. Third European Conference on Infections in Leukemia (ECIL-3). \u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis. 2012;54(5):633\u201343 (Review).","journal-title":"Clin Infect Dis"},{"issue":"6","key":"61_CR16","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","volume":"42","author":"M Kawazu","year":"2004","unstructured":"Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1\u21923)-\u03b2-d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol. 2004;42(6):2733\u201341.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"61_CR17","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1086\/588295","volume":"46","author":"T Obayashi","year":"2008","unstructured":"Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1\u21923)-\u03b2-d-glucan assay for the diagnosis of invasive fungal infections\u2013a study based on autopsy cases from 6 years. Clin Infect Dis. 2008;46(12):1864\u201370.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"61_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","volume":"39","author":"Z Odabasi","year":"2004","unstructured":"Odabasi Z, Mattiuzzi G, Estey E, et al. \u03b2-d-Glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004;39(2):199\u2013205.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"61_CR19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","volume":"41","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner L, Alexander BD, et al. Multicenter clinical evaluation of the (1\u21923)-\u03b2-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41(5):654\u20139.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"61_CR20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","volume":"49","author":"S Koo","year":"2009","unstructured":"Koo S, Bryar JM, Page JH, et al. Diagnostic performance of the (1\u21923)-\u03b2-d-glucan assay for invasive fungal disease. Clin Infect Dis. 2009;49(11):1650\u20139.","journal-title":"Clin Infect Dis"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1099\/jmm.0.019299-0","volume":"59","author":"Z Racil","year":"2010","unstructured":"Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J. Difficulties in using 1,3-\u03b2-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies: high frequency of false-positive results and their analysis. J Med Microbiol. 2010;59:1016\u201322.","journal-title":"J Med Microbiol"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1620\/tjem.217.117","volume":"217","author":"H Kanamori","year":"2009","unstructured":"Kanamori H, Kanemitsu K, Miyazak T, et al. Measurement of (1-3)-\u03b2-d-glucan derived from different gauze types. Tohoku J Exp Med. 2009;217:117\u201321.","journal-title":"Tohoku J Exp Med"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1755.2001.00802.x","volume":"60","author":"H Kanda","year":"2001","unstructured":"Kanda H, Kubo K, Hamasak K, Kanda Y, Nakao A, Kitamura T, Fujita T, Yamamoto K, Mimura T. Influence of various hemodialysis membranes on the plasma (1\u21923)-\u03b2-d-glucan level. Kidney Int. 2001;60:319\u201323.","journal-title":"Kidney Int"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/AAC.00658-06","volume":"50","author":"FM Marty","year":"2006","unstructured":"Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1\u21923)-\u03b2-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother. 2006;50:3450\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s100470300008","volume":"6","author":"K Nagasawa","year":"2003","unstructured":"Nagasawa K, Yano T, Kitabayashi G, Morimoto H, Yamada Y, Ohata A, Usami M, Horiuchi T. Experimental proof of contamination of blood components by (1,3)-\u03b2-d-glucan caused by filtration with cellulose filters in the manufacturing process. J Artif Organs. 2003;6:49\u201354.","journal-title":"J Artif Organs"},{"issue":"5","key":"61_CR26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0196-0644(99)70346-X","volume":"33","author":"SR Hayden","year":"1999","unstructured":"Hayden SR, Brown MD. Likelihood ratio: a powerful tool for incorporating the results of a diagnostic test into clinical decision making. Ann Emerg Med. 1999;33(5):575\u201380.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"61_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1439-0507.2012.02195.x","volume":"56","author":"G Metan","year":"2013","unstructured":"Metan G, Ko\u00e7 AN, Kaynar LG, et al. What is the role of the (1\u21923)-\u03b2-D-glucan assay in the screening of patients undergoing autologous haematopoietic stem-cell transplantation? Mycoses. 2013;56(1):34\u20138.","journal-title":"Mycoses"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-016-0061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-016-0061-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-016-0061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:34:50Z","timestamp":1498329290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-016-0061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":27,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s11046-016-0061-0","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}